Fungal Feelings in the Irritable Bowel Syndrome: the Intestinal Mycobiome and Abdominal Pain

Overview

Journal Gut Microbes

Specialties Gastroenterology
Microbiology

Date 2023 Feb 1

PMID 36723172

Authors

Iam van Thiel

Wj de Jonge

Rm van den Wijngaard

Affiliations

Soon will be listed here.

Abstract

Although the gut microbiota consists of bacteria, viruses, and fungi, most publications addressing the microbiota-gut-brain axis in irritable bowel syndrome (IBS) have a sole focus on bacteria. This may relate to the relatively low presence of fungi and viruses as compared to bacteria. Yet, in the field of inflammatory bowel disease research, the publication of several papers addressing the role of the intestinal mycobiome now suggested that these low numbers do not necessarily translate to irrelevance. In this review, we discuss the available clinical and preclinical IBS mycobiome data, and speculate how these recent findings may relate to earlier observations in IBS. By surveying literature from the broader mycobiome research field, we identified questions open to future IBS-oriented investigations.

Citing Articles

Irritable Bowel Syndrome: A Hallmark of Psychological Distress in Women?.

Marano G, Traversi G, Pola R, Gasbarrini A, Gaetani E, Mazza M Life (Basel). 2025; 15(2).

PMID: 40003686 PMC: 11856493. DOI: 10.3390/life15020277.

Predicting cancer-related mycobiome aspects in gastrointestinal cancers: a systematic review.

Szklenarik G, Kiraly P, Szegvari G, Dora D, Lohinai Z Front Med (Lausanne). 2024; 11:1488377.

PMID: 39678030 PMC: 11637848. DOI: 10.3389/fmed.2024.1488377.

Supplementation with NS8 alleviated behavioral, neural, endocrine, and microbiota abnormalities in an endogenous rat model of depression.

Alatan H, Liang S, Shimodaira Y, Wu X, Hu X, Wang T Front Immunol. 2024; 15:1407620.

PMID: 39346901 PMC: 11428200. DOI: 10.3389/fimmu.2024.1407620.

The gut microbiome in disorders of gut-brain interaction.

Kraimi N, Ross T, Pujo J, Palma G Gut Microbes. 2024; 16(1):2360233.

PMID: 38949979 PMC: 11218806. DOI: 10.1080/19490976.2024.2360233.

The role of the gut microbiome in disorders of gut-brain interaction.

Gawey B, Mars R, Kashyap P FEBS J. 2024; .

PMID: 38922780 PMC: 11664017. DOI: 10.1111/febs.17200.

References

Pittayanon R, Lau J, Yuan Y, Leontiadis G, Tse F, Surette M . Gut Microbiota in Patients With Irritable Bowel Syndrome-A Systematic Review. Gastroenterology. 2019; 157(1):97-108. DOI: 10.1053/j.gastro.2019.03.049. View

Naglik J, Gaffen S, Hube B . Candidalysin: discovery and function in Candida albicans infections. Curr Opin Microbiol. 2019; 52:100-109. PMC: 6687503. DOI: 10.1016/j.mib.2019.06.002. View

Lapiere A, Richard M . Bacterial-fungal metabolic interactions within the microbiota and their potential relevance in human health and disease: a short review. Gut Microbes. 2022; 14(1):2105610. PMC: 9341359. DOI: 10.1080/19490976.2022.2105610. View

Amadesi S, Nie J, Vergnolle N, Cottrell G, Grady E, Trevisani M . Protease-activated receptor 2 sensitizes the capsaicin receptor transient receptor potential vanilloid receptor 1 to induce hyperalgesia. J Neurosci. 2004; 24(18):4300-12. PMC: 6729438. DOI: 10.1523/JNEUROSCI.5679-03.2004. View

Zwadlo-Klarwasser G, Braam U, Jungbluth C, Schmutzler W . Time-course of the histamine release from human peripheral blood monocytes and the influence of ketotifen and disodium cromoglycate (DSCG). Inflamm Res. 1995; 44 Suppl 1:S18-9. DOI: 10.1007/BF01674375. View

Vergnolle N, Bunnett N, Sharkey K, Brussee V, Compton S, Grady E . Proteinase-activated receptor-2 and hyperalgesia: A novel pain pathway. Nat Med. 2001; 7(7):821-6. DOI: 10.1038/89945. View

Kaila B, Orr K, Bernstein C . The anti-Saccharomyces cerevisiae antibody assay in a province-wide practice: accurate in identifying cases of Crohn's disease and predicting inflammatory disease. Can J Gastroenterol. 2005; 19(12):717-21. DOI: 10.1155/2005/147681. View

Simren M, Tornblom H, Palsson O, van Tilburg M, Van Oudenhove L, Tack J . Visceral hypersensitivity is associated with GI symptom severity in functional GI disorders: consistent findings from five different patient cohorts. Gut. 2017; 67(2):255-262. DOI: 10.1136/gutjnl-2016-312361. View

McFarland L, Karakan T, Karatas A . Strain-specific and outcome-specific efficacy of probiotics for the treatment of irritable bowel syndrome: A systematic review and meta-analysis. EClinicalMedicine. 2021; 41:101154. PMC: 8529205. DOI: 10.1016/j.eclinm.2021.101154. View

10.

Ingrosso M, Ianiro G, Nee J, Lembo A, Moayyedi P, Black C . Systematic review and meta-analysis: efficacy of peppermint oil in irritable bowel syndrome. Aliment Pharmacol Ther. 2022; 56(6):932-941. DOI: 10.1111/apt.17179. View

11.

Aguilera-Lizarraga J, Florens M, Viola M, Jain P, Decraecker L, Appeltans I . Local immune response to food antigens drives meal-induced abdominal pain. Nature. 2021; 590(7844):151-156. PMC: 7610810. DOI: 10.1038/s41586-020-03118-2. View

12.

van den Wijngaard R, Klooker T, de Jonge W, Boeckxstaens G . Peripheral relays in stress-induced activation of visceral afferents in the gut. Auton Neurosci. 2009; 153(1-2):99-105. DOI: 10.1016/j.autneu.2009.07.004. View

13.

Bashashati M, Moossavi S, Cremon C, Barbaro M, Moraveji S, Talmon G . Colonic immune cells in irritable bowel syndrome: A systematic review and meta-analysis. Neurogastroenterol Motil. 2017; 30(1). DOI: 10.1111/nmo.13192. View

14.

Wouters M, Balemans D, Van Wanrooy S, Dooley J, Cibert-Goton V, Alpizar Y . Histamine Receptor H1-Mediated Sensitization of TRPV1 Mediates Visceral Hypersensitivity and Symptoms in Patients With Irritable Bowel Syndrome. Gastroenterology. 2016; 150(4):875-87.e9. DOI: 10.1053/j.gastro.2015.12.034. View

15.

Yamaguchi N, Sugita R, Miki A, Takemura N, Kawabata J, Watanabe J . Gastrointestinal Candida colonisation promotes sensitisation against food antigens by affecting the mucosal barrier in mice. Gut. 2006; 55(7):954-60. PMC: 1856330. DOI: 10.1136/gut.2005.084954. View

16.

Hong G, Li Y, Yang M, Li G, Qian W, Xiong H . Gut fungal dysbiosis and altered bacterial-fungal interaction in patients with diarrhea-predominant irritable bowel syndrome: An explorative study. Neurogastroenterol Motil. 2020; 32(11):e13891. DOI: 10.1111/nmo.13891. View

17.

Walker L, Aldhous M, Drummond H, Smith B, Nimmo E, Arnott I . Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations. Clin Exp Immunol. 2004; 135(3):490-6. PMC: 1808965. DOI: 10.1111/j.1365-2249.2003.02392.x. View

18.

McFarland L, Evans C, Goldstein E . Strain-Specificity and Disease-Specificity of Probiotic Efficacy: A Systematic Review and Meta-Analysis. Front Med (Lausanne). 2018; 5:124. PMC: 5949321. DOI: 10.3389/fmed.2018.00124. View

19.

Whelan K, Staudacher H . Low FODMAP diet in irritable bowel syndrome: a review of recent clinical trials and meta-analyses. Curr Opin Clin Nutr Metab Care. 2022; 25(5):341-347. DOI: 10.1097/MCO.0000000000000854. View

20.

Botschuijver S, Welting O, Levin E, Maria-Ferreira D, Koch E, Montijn R . Reversal of visceral hypersensitivity in rat by Menthacarin , a proprietary combination of essential oils from peppermint and caraway, coincides with mycobiome modulation. Neurogastroenterol Motil. 2018; 30(6):e13299. DOI: 10.1111/nmo.13299. View